Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT - Get Free Report)'s share price traded down 7.1% during trading on Tuesday . The stock traded as low as $10.29 and last traded at $10.17. 622,957 shares were traded during mid-day trading, a decline of 56% from the average session volume of 1,426,101 shares. The stock had previously closed at $10.95.
Analyst Upgrades and Downgrades
Several equities analysts have commented on the company. TD Cowen downgraded Calumet Specialty Products Partners from a "buy" rating to a "hold" rating and cut their price objective for the company from $26.00 to $16.00 in a research report on Tuesday, March 4th. StockNews.com raised Calumet Specialty Products Partners to a "sell" rating in a research report on Monday, November 18th. Wells Fargo & Company cut their price objective on Calumet Specialty Products Partners from $29.00 to $28.00 and set an "overweight" rating on the stock in a research report on Wednesday, March 5th. UBS Group downgraded Calumet Specialty Products Partners from a "neutral" rating to a "sell" rating and dropped their price target for the stock from $20.50 to $15.00 in a research report on Tuesday, February 4th. Finally, HC Wainwright reissued a "buy" rating and set a $33.00 price target on shares of Calumet Specialty Products Partners in a research report on Monday, March 3rd. Two investment analysts have rated the stock with a sell rating, one has given a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus target price of $21.40.
View Our Latest Stock Report on Calumet Specialty Products Partners
Calumet Specialty Products Partners Price Performance
The business has a 50-day moving average of $16.46 and a two-hundred day moving average of $18.86. The company has a market cap of $1.04 billion, a P/E ratio of -4.37 and a beta of 1.88.
Calumet Specialty Products Partners (NASDAQ:CLMT - Get Free Report) last issued its quarterly earnings data on Friday, February 28th. The oil and gas company reported ($0.47) earnings per share for the quarter, beating analysts' consensus estimates of ($1.06) by $0.59. The company had revenue of $949.50 million for the quarter, compared to the consensus estimate of $921.76 million. During the same period in the previous year, the business earned ($0.59) EPS. Calumet Specialty Products Partners's revenue for the quarter was down 2.8% compared to the same quarter last year. Equities analysts anticipate that Calumet Specialty Products Partners, L.P. will post -3.02 EPS for the current fiscal year.
Insider Activity at Calumet Specialty Products Partners
In other Calumet Specialty Products Partners news, Director Jennifer Straumins sold 37,861 shares of the stock in a transaction dated Wednesday, December 18th. The stock was sold at an average price of $21.42, for a total value of $810,982.62. Following the completion of the sale, the director now directly owns 1,184,589 shares in the company, valued at approximately $25,373,896.38. This trade represents a 3.10 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CFO David Lunin purchased 2,500 shares of the firm's stock in a transaction on Tuesday, March 4th. The stock was acquired at an average price of $13.05 per share, with a total value of $32,625.00. Following the completion of the purchase, the chief financial officer now owns 2,500 shares of the company's stock, valued at $32,625. The trade was a ∞ increase in their position. The disclosure for this purchase can be found here. 2.91% of the stock is owned by corporate insiders.
Calumet Specialty Products Partners Company Profile
(
Get Free Report)
Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.
See Also
Before you consider Calumet Specialty Products Partners, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Calumet Specialty Products Partners wasn't on the list.
While Calumet Specialty Products Partners currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for April 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.